News

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health…
Read More...

SPI Pharma introduces UltraBurst, providing a step-change in the most critical orally disintegrating tablet (ODT) characteristics — dissolution time. It is an innovative excipient…
Read More...

Everest Medicines a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in …
Read More...

NRx Pharmaceuticals a clinical stage pharmaceutical company announced that it has signed a Memorandum Of Understanding with the Government of Israel to license exclusive worldwide…
Read More...

I-Mab a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, announced the signing of two new collaborations with…
Read More...

AstraZeneca’s Biologics License Application (BLA) for tezepelumab has been accepted and granted Priority Review for the treatment of asthma from the US Food and Drug Administration…
Read More...

Verge Genomics, a biotech company that has created an industry leading all-in-human, artificial-intelligence-powered drug discovery and development platform focused on therapies for…
Read More...

INBRAIN Neuroelectronics, a company at the intersection of medtech, deeptech and digital health dedicated to developing the world’s first graphene-based intelligent neuroelectronic…
Read More...

LGM Pharma announced the launch of its new Analytical Services offering that provides analytical testing and stability services to pharmaceutical developers and manufacturers, including…
Read More...

Funding from the COVID-19 Therapeutics Accelerator to advance Exscientia’s novel class of AI-designed coronavirus SARS-CoV-2 Mpro inhibitors to development candidates OXFORD, U.K. --…
Read More...

Sequanta Technologies Co., Ltd. and Mission Bio. are pleased to announce that they have entered into a strategic partnership, providing high-quality single-cell sequence services using…
Read More...

SRI International (SRI) announced that the company has entered a research collaboration with Sanofi. By leveraging SRI’s SynFini platform, an artificial intelligence (AI)-guided,…
Read More...

For gene therapy developers seeking to rapidly and efficiently scale production, a set of solutions is now available from Thermo Fisher Scientific to support adeno-associated viral…
Read More...

United States Pharmacopeia (USP), an independent, scientific nonprofit organization, is pleased to announce the acquisition of Pharmatech Associates, Inc. By adding Pharmatech…
Read More...

Vaxart, Inc. a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced that it has signed an…
Read More...

Algernon Pharmaceuticals Inc. a clinical stage pharmaceutical development company, announces that it has reached 70% of its enrollment target for its Phase 2 clinical study of its…
Read More...

Eureka Therapeutics, Inc. announced that Eureka and Memorial Sloan Kettering Cancer Center (MSK) entered into a license agreement with Sanofi for the non-CAR use of a novel, human…
Read More...

Everest Medicines a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products for patients in Greater China and other parts of Asia,…
Read More...

Altogen Labs, a preclinical CRO, provides essential safety and efficacy testing for novel medicines (GLP-compliant pharm/tox assays per FDA IND requirements). Company works with…
Read More...

Standigm Inc. a leading workflow artificial intelligence (AI) drug discovery company, and SK Chemicals Co., Ltd a life science and green chemicals company, announced today that they…
Read More...